| Shares Acquired | 53.54 Lakh11.91% Stake |
|---|---|
| Market Cap | ₹18,524.68 CrAgrochemicals |
| Net Profit TTM | ₹689.2 Cr21.34% Growth |
| Durability Score | 80High Durability |
Key highlights
- Acquisition of 53,54,030 equity shares representing an 11.91% voting stake
- Transaction executed as an inter-se transfer between promoters on July 8, 2026
- Bayer AG direct holding rose from 8.43% to 20.34% post-acquisition
- Shares purchased from fellow promoter entity Bayer CropScience AG
- Company equity share capital remains constant at 4,49,42,092 shares
Details of the Inter-se Transfer
The transaction involved a transfer of equity shares within the promoter group of Bayer CropScience Limited. Bayer AG, already a promoter holding 37,88,433 shares, acquired an additional 53,54,030 shares from Bayer CropScience AG, another promoter entity. This acquisition was finalized on July 8, 2026, using the block deal mechanism on the stock exchange.
Following this transfer, the total number of shares held by Bayer AG stands at 91,42,463, which consolidates its direct influence over the Indian subsidiary's voting capital to over one-fifth of the total shareholding.
Consolidated Promoter Structure
- The acquirer, Bayer AG, is part of the core promoter group for the Target Company
- Persons Acting in Concert include Bayer SAS, Monsanto Company, and Bayer Vapi Private Limited
- The deal does not change the total promoter group holding but redistributes shares between entities
- Total diluted share capital is confirmed at 4,49,42,092 shares of face value INR 10 each
- The disclosure follows mandatory requirements under SEBI Substantial Acquisition of Shares and Takeovers
Business and Operational Profile
Bayer CropScience Limited operates as a leading player in the Indian agrochemicals sector, providing a broad range of products including herbicides, fungicides, insecticides, and seeds. The company integrates digital farming solutions with traditional crop protection to enhance agricultural productivity. Its operations are backed by strong research and development, focusing on sustainable farming practices.
With a market capitalization exceeding eighteen thousand crore rupees, the company maintains a dominant position in the chemicals and petrochemicals segment, serving both domestic and international markets.
Financial and Market Performance
The company exhibits robust financial health with an annual operating revenue of 5,675 crore rupees and a net profit growth of 21.34% year-over-year. Current quarterly results show a net profit of 162.1 crore rupees, representing a 13.12% increase compared to the same period last year. With a Durability Score of 80, the firm is categorized as a mid-range performer.
While the stock has seen a one-year price decline of 36.03%, its return on equity remains strong at 23.23%, outperforming the sector average of 13.58%.
| Share price | ₹4121.9 |
|---|---|
| Market capitalisation | ₹18,524.68 Cr |
| Revenue (annual) | ₹5,675.00 Cr |
| Net profit (annual) | ₹689.20 Cr |
| Revenue (latest quarter) | ₹1,100.80 Cr-0.49% vs previous quarter |
| Net profit (latest quarter) | ₹162.10 Cr+69.38% vs previous quarter |
| P/E (TTM) | 26.88×Sector 43.9× |
| Promoter holding | 71.43%0.00% QoQ |
| FII holding | 3.89%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Bayer CropScience Limited announcing an inter-se transfer of shares between promoters. Market figures from a third-party data provider.
